Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Banchereau · SciRah

Researcher profile · Semantic Scholar

R. Banchereau

Share profile

R. Banchereau — researcher profile on SciRah

h-index: 36
Works: 62
Citations: 15K

Most-cited papers

TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S. Mariathasan, S. Turley, D. Nickles, A. Castiglioni +38 more
2018Nature4,798 citations Open access
Semantic Scholar
An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis
M. Berry, C. Graham, Finlay W Mcnab, Zhao-Hui Xu +17 more
2010Nature1,857 citations Open access
Semantic Scholar
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
T. Powles, I. Durán, M. S. van der Heijden, Y. Loriot +20 more
2018The Lancet1,249 citations Open access
Semantic Scholar
Peripheral T cell expansion predicts tumour infiltration and clinical response
Thomas D. Wu, Shravan Madireddi, P. D. de Almeida, R. Banchereau +25 more
2020Nature657 citations
Semantic Scholar
Personalized Immunomonitoring Uncovers Molecular Networks That Stratify Lupus Patients
R. Banchereau, Seunghee Hong, Brandi Cantarel, Nicole E. Baldwin +19 more
2016Cell651 citations Open access
Semantic Scholar
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
T. Powles, Z. Assaf, N. Davarpanah, R. Banchereau +23 more
2021Nature612 citations
Semantic Scholar
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
T. Powles, M. Kockx, A. Rodríguez-Vida, I. Durán +21 more
2019Nature Medicine535 citations Open access
Semantic Scholar
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
R. Motzer, R. Banchereau, H. Hamidi, T. Powles +18 more
2020Cancer Cell495 citations Open access
Semantic Scholar
Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
S. Caielli, Shruti Athale, Bojana Domic, Elise Murat +12 more
2016Journal of Experimental Medicine479 citations Open access
Semantic Scholar
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
Akshay T. Krishnamurty, Justin A. Shyer, M. Thai, Vineela Gandham +27 more
2022Nature375 citations Open access
Semantic Scholar
High systemic and tumor-associated IL8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe Yuen, Li-Fen Liu, Vinita Gupta, Shravan Madireddi +22 more
2020Nature Medicine370 citations Open access
Semantic Scholar
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer.
N. Patil, B. Nabet, Sören Müller, H. Koeppen +17 more
2022Cancer Cell349 citations Open access
Semantic Scholar
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
B. Szabados, M. Kockx, Z. Assaf, Pieter-Jan van Dam +26 more
2022European Urology187 citations Open access
Semantic Scholar
A CD4+ T cell population expanded in Lupus blood provides B cell help through IL10 and succinate
S. Caielli, Diogo F. T. Veiga, Preetha Balasubramanian, Shruti Athale +18 more
2018Nature Medicine184 citations Open access
Semantic Scholar
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.
R. Motzer, T. Powles, M. Atkins, B. Escudier +16 more
2021JAMA Oncology169 citations Open access
Semantic Scholar
Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in lupus patients
Y. Kotliarov, R. Sparks, A. Martins, Matthew P. Mulè +13 more
2020Nature Medicine141 citations Open access
Semantic Scholar
Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
R. Banchereau, Avantika Chitre, A. Scherl, Thomas D. Wu +26 more
2021Journal for ImmunoTherapy of Cancer135 citations Open access
Semantic Scholar
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
Te-Chia Wu, Kangling Xu, J. Martínek, R. Young +22 more
2018Cancer Research132 citations Open access
Semantic Scholar
Molecular determinants of response to PD-L1 blockade across tumor types
R. Banchereau, Ning Leng, Oliver A. Zill, E. Sokol +21 more
2021Nature Communications130 citations Open access
Semantic Scholar
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
B. Salomé, J. Sfakianos, D. Ranti, J. Daza +47 more
2022Cancer Cell123 citations Open access
Semantic Scholar
Host Immune Transcriptional Profiles Reflect the Variability in Clinical Disease Manifestations in Patients with Staphylococcus aureus Infections
R. Banchereau, A. Jordán-Villegas, M. Ardura, A. Mejías +11 more
2012PLoS ONE105 citations Open access
Semantic Scholar
Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics
R. Banchereau, A. Cepika, J. Banchereau, V. Pascual
2017Annual Review of Immunology88 citations Open access
Semantic Scholar
Enhanced Monocyte Response and Decreased Central Memory T Cells in Children with Invasive Staphylococcus aureus Infections
M. Ardura, R. Banchereau, A. Mejías, T. Di Pucchio +6 more
2009PLoS ONE87 citations Open access
Semantic Scholar
A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4
L. Alsina, E. Israelsson, Matthew C. Altman, Kristen K. Dang +15 more
2014Nature Immunology76 citations Open access
Semantic Scholar
Reprogramming tumor-infiltrating dendritic cells for CD103+CD8+ mucosal T cell differentiation and breast cancer rejection
Te-Chia Wu, Kangling Xu, R. Banchereau, F. Marches +12 more
2014Cancer immunology research76 citations Open access
Semantic Scholar
How to evaluate a gastric submucosal tumour in a patient with haematemesis?
S. A. Keilbaugh, M. Shin, R. Banchereau, L. McVay +4 more
2005Gut73 citations Open access
Semantic Scholar
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy
Seunghee Hong, R. Banchereau, Bat-Sheva L. Maslow, M. Guerra +23 more
2019Journal of Experimental Medicine71 citations Open access
Semantic Scholar
Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC).
B. Rini, M. Huseni, M. Atkins, D. McDermott +13 more
2018Annals of Oncology70 citations Open access
Semantic Scholar
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
M. Galsky, Xiang-Nan Guan, Deepali Rishipathak, Aaron S. Rapaport +29 more
2024Cell Reports Medicine60 citations Open access
Semantic Scholar
Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines
R. Banchereau, Nicole E. Baldwin, A. Cepika, Shruti Athale +18 more
2014Nature Communications59 citations Open access
Semantic Scholar
A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis
A. Cepika, R. Banchereau, É. Segura, Marina Ohouo +17 more
2017Journal of Experimental Medicine55 citations Open access
Semantic Scholar
Activation of RegIIIbeta/gamma and interferon gamma expression in the intestinal tract of SCID mice: an innate response to bacterial colonisation of the gut.
S. A. Keilbaugh, M. Shin, R. Banchereau, L. McVay +4 more
2005Gut53 citations
Semantic Scholar
Open‐Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
J. Aróstegui, J. Antón, I. Calvo, Á. Robles +8 more
2017Arthritis & Rheumatology48 citations
Semantic Scholar
Intracellular Bacteria Interfere with Dendritic Cell Functions: Role of the Type I Interferon Pathway
Laurent Gorvel, J. Textoris, R. Banchereau, A. Ben Amara +7 more
2014PLoS ONE46 citations Open access
Semantic Scholar
Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells
Anna R. Martirosyan, Camino Pérez-Gutiérrez, R. Banchereau, H. Dutartre +15 more
2012PLoS Pathogens42 citations Open access
Semantic Scholar
Atezolizumab (atezo) vs. chemotherapy (chemo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Immune biomarkers, tumor mutational burden (TMB), and clinical outcomes from the phase III IMvigor211 study.
T. Powles, Y. Loriot, A. Ravaud, N. Vogelzang +16 more
201839 citations
Semantic Scholar
Tumor, immune, and stromal characteristics associated with clinical outcomes with atezolizumab (atezo) + platinum-based chemotherapy (PBC) or atezo monotherapy (mono) versus PBC in metastatic urothelial cancer (mUC) from the phase III IMvigor130 study.
M. Galsky, R. Banchereau, H. Hamidi, Ning Leng +15 more
2020Journal of Clinical Oncology33 citations
Semantic Scholar
Influenza Vaccines Differentially Regulate the Interferon Response in Human Dendritic Cell Subsets
Shruti Athale, R. Banchereau, L. Thompson-Snipes, Yuanyuan Wang +3 more
2017Science Translational Medicine31 citations Open access
Semantic Scholar
Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments
D. Duluc, R. Banchereau, Julien Gannevat, L. Thompson-Snipes +11 more
2014Genome Medicine25 citations Open access
Semantic Scholar
Brucella CβG induces a dual pro- and anti-inflammatory response leading to a transient neutrophil recruitment
C. Degos, A. Gagnaire, R. Banchereau, I. Moriyón +1 more
2015Virulence20 citations Open access
Semantic Scholar
658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)
M. Galsky, X. Guan, R. Banchereau, Li Wang +16 more
2021Annals of Oncology17 citations Open access
Semantic Scholar
Systems Approaches to Human Autoimmune Diseases
R. Banchereau, A. Cepika, V. Pascual
2013Current Opinion in Immunology16 citations Open access
Semantic Scholar
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Xiao Li, J. Eastham, J. Giltnane, W. Zou +15 more
2023bioRxiv13 citations Open access
Semantic Scholar
A tumor-promoting inflammatory SPP1+ macrophage—IL-6—CRP axis drives immune dysfunction in bladder cancer
M. Tran, B. A. Cho, S. Izadmehr, Seong-Keun Yoo +34 more
2026Cancer Discovery12 citations Open access
Semantic Scholar
Atezolizumab (atezo) monotherapy versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinoma (mUC): Clinical outcomes by PD-L1 status in cisplatin (cis)-ineligible pts from the phase III IMvigor130 study.
M. Galsky, A. Bamias, J. Á. Arranz Arija, I. Davis +16 more
202110 citations
Semantic Scholar
Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe Yuen, Li-Fen Liu, Vinita Gupta, Shravan Madireddi +22 more
2021Nature Medicine9 citations Open access
Semantic Scholar
OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
F. Oezkan, K. He, D. Owen, Maciej Pietrzak +26 more
2019Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
1735O PD-L1 expression on immune cells by SP142 co-localises with dendritic cells and is associated with improved overall survival (OS) with atezolizumab in patients with untreated metastatic urothelial cancer (mUC)
E. G. Pulido, M. Galsky, R. VanElzen, R. Banchereau +16 more
2022Annals of Oncology3 citations Open access
Semantic Scholar
Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI).
B. Szabados, Mariano Ponz-Sarvis, Robson J. M. Machado, Diego Saldana +6 more
2022Clinical Cancer Research3 citations
Semantic Scholar
435 Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
N. Patil, B. Nabet, Sören Müller, H. Koeppen +11 more
2022Regular and Young Investigator Award Abstracts3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Mariathasan×20
Invite
S. Mariathasan — researcher profile on SciRah
V. Pascual×18
Invite
V. Pascual — researcher profile on SciRah
T. Powles×14
Invite
T. Powles — researcher profile on SciRah
J. Banchereau×14
Invite
J. Banchereau — researcher profile on SciRah

×9

Invite

E. Kadel — researcher profile on SciRah

Invite

H. Koeppen — researcher profile on SciRah

Invite

P. Hegde — researcher profile on SciRah

Invite

Ning Leng — researcher profile on SciRah

Invite

Kobe Yuen — researcher profile on SciRah

M. S. van der Heijden×7

Invite

M. S. van der Heijden — researcher profile on SciRah

Invite

M. Huseni — researcher profile on SciRah

Nicole E. Baldwin×7

Invite

Nicole E. Baldwin — researcher profile on SciRah